Gni Group Ltd. (2160) Press Release
Consolidated Financial Results for Q2 FY2026 (IFRS)
Earlier from Gni
- Notice Concerning the Completion of the Acquisition of All Shares of AYUMI Pharmaceutical Holdings KK (Conversion into a Wholly-Owned Subsidiary)
- Notice Regarding the Execution of a Loan Agreement Containing Financial Covenants
- Notice Concerning Filing of Form S-3 Registration Statement by Gyre Therapeutics
- GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company